Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Clinical trials of (+)-calanolide A in HIV-positive patients expanded to Malaysia & Singapore

July 16, 1999

Agents for AIDS extracted from plant source

July 14, 1999

Roche to develop and market Trimeris's HIV fusion inhibitors

July 13, 1999

E.U.-wide approval obtained for Ziagen

July 12, 1999

Inhibitors of P. carinii and T. gondii DHFR developed at U.S. universities

July 12, 1999

Aromatic hydrazones from Uniroyal with anti-HIV-1 activity encompassing mutant strains

July 12, 1999

BTG acquires novel technology for treatment of HIV

July 12, 1999

Pediatric formulation of Viramune now available in the E.U.

July 9, 1999

Boston Biomedica awarded SBIR grant to develop natural product-based HIV drug candidates

July 8, 1999

Ritonavir found to be more potent inhibitor of P-glycoprotein than SDZ-PSC-833

July 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.